Back to the feed
In brief
On 26.11.2025, a person holding the function "Non-executive member of the board of directors" at Newron Pharmaceuticals S.p.A. disclosed a sale worth CHF 247’984 to SIX Exchange Regulation.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A non-executive member of the board of directors of Newron Pharmaceuticals S.p.A. declared a "Sale" transaction on 26.11.2025.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date26.11.2025
Issuing companyNewron Pharmaceuticals S.p.A.
Transaction sideSale
Management functionNon-executive member of the board of directors
Security typeRegistered shares
SecurityEXERSALE - Exercise price Eur 10.06
Quantity14’567
Unit priceCHF 17.02
AmountCHF 247’984
ExchangeXSWX
Notification IDT1PBQ00061
Other Newron Pharmaceuticals S.p.A. insider transactions
- Purchase · Executive member of the board of directors / senior management08.10.2026CHF 10’781
- Purchase · Executive member of the board of directors / senior management12.08.2026CHF 23’613
- Purchase · Executive member of the board of directors / senior management11.08.2026CHF 23’962
- Sale · Non-executive member of the board of directors02.12.2025CHF 104’218
- Purchase · Non-executive member of the board of directors23.04.2025CHF 5’472
These figures aggregate public disclosures. They are not investment advice.